| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
|
|
01-11-2018, 01:00 AM
|
#1 | ||
|
|||
|
Member
|
I found it to be quite interesting and very readable. Most of the usual suspects get a mention.
The road ahead: Parkinson’s research in 2 18 | The Science of Parkinson's disease |
||
|
 Reply With Quote
|
|
01-11-2018, 03:04 AM
|
#2 | ||
|
|||
|
Senior Member
|
An excellent blog. Simon Stott, a researcher at Cambridge University, is doing a great job communicating the science of PD.
It's not a criticism of him, but what benefit will PwP get from any of this in 2018, or 2019, or 2020 ... ? There's always going to be a lag between research and general use, so perhaps the question that I should be asking is: What new therapies for PD will be introduced in 2018? John
__________________
Born 1955. Diagnosed PD 2005. Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg |
||
|
|
Reply With Quote
|
| "Thanks for this!" says: | jeffreyn (01-11-2018) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| SoPD overview of Deep Brain Stimulation (including research on 'no surgery' option) | Parkinson's Disease | |||
| overview conducted research in neuroprotectiveness | Parkinson's Disease | |||
| Interesting overview of non-drug research | Parkinson's Disease | |||
SoPD blog's overview of the state-of-play concerning PD research in 2018
Hybrid Mode
